Chromosomal localization of three human cytochrome P450 genes belonging to the CYP2C 'subfamily (CYP2C8, 2C9, and 2C10) was identified by fluorescence in situ hybridization (FISH). An original MP-8 clone was used as a DNA probe for the assignment of the CYP2C10 gene, while two cDNA probes, a 1.37 kb fragment of CYP2C8 and a 1.19 kb fragment of CYP2C9, were obtained after amplifying the predicted fragments (MP-20 and MP-4 clones, respectively) by polymerase chain reaction using a single human liver cDNA library. The results showed that three human CYP2C8, 2C9, and 2C10 cDNAs were located at the same subchromosomal region, 10q24.1.
INTRODUCTION
The human liver microsomal cytochrome P450 (P450) enzymes encoded by the CYP2C subfamily are known to catalyze the oxidation of mephenytoin and to exhibit genetic polymorphism of metabolism in humans (Wedlund et aL, 1984; Kupfer and Preisig, 1984) . Shimada et aL (1986) first isolated two similar forms of human liver P450 enzymes responsible for (S)-mephenytoin 4-hydroxylation, termed P-450~.~_ 1 and P-450~p_~. Furthermore, Umbenhauer et al. (1987) and Ged et al. (1988) have isolated four cDNA clones that contained nearly full-length DNA sequences, from a bacteriophage Xgtl 1 library prepared from a single human liver using anti-P450~e_l as a probe, and designated them as MP-12 (CYP2C8), MP-20 (CYP2C8), MP-4 (CYP2C9), and MP-8 (CYP2C10). Recently, CYP2C9 and CYP2C10 enzymes have been reported to catalyze tolbutamide methyl hydroxylation and hexobarbital 3'-hydroxylation (Brian et al., 1989; Srivastava et al., I991 ; Yasumori et aL, 1991) , and CYP2C8 enzyme is found to be one of the benzo-(a)pyrene 3-hydroxylases (Yun et al., 1992) . Although the human P450 gene(s) encoding the CYP2C subfamily was mapped to 10q24.1-10q24.3 by a panel of human-rodent somatic cell hybrids and isotopic in situ hybridization (Okino et at., t987; RiddelI et aL, t987; Meehan et aL, 1988) , the exact localization of this multigene family remains unclear.
In the present study, we mapped the human CYP2C subfamily genes (CYP2C8, 2C9, and 2Cl0) by fluorescence in situ hybridization (FISH) combined with replication R-bands on prometaphase chromosomes (Inoue et aI., 1992 ). An original MP-8 clone was used as a DNA probe to assign the CYP2C10 gene. A 1.37-kb and a 1.19-kb fragment of CYP2C8 and 2C9 respectively, were amplified separately from the liver cDNA library by the polymerase chain reaction (PCR) and subcloned into the pBluescriptIIKS(+) vector. The amplified products were confirmed by DNA sequencing, and used to assign the chromosomal localization by FISH. primers and PCR (CYP2C8 and 2C9) . In order to obtain the CYP2C eDNA probes, two CYP2C cDNAs corresponding to clones MP-20 (CYP2CS) and MP-4 (CYP2C9) were amplified from a liver cDNA library by PCR. Oligonueleotide (20-met) primers were chemically synthesized on an Applied Biosystems 380A DNA synthesizer (Foster City, CA) using cyanoethyl phosphoramidite chemistry according to the published CYP2C8 and CYP2C9 eDNA sequences (Brian et aL, 1989; Ged et aL, 1988) . After detritylation and alkaline deprotection, the crude material was used for all applications without further purification. Primer pairs from CYP2C8 eDNA included: 5'-TCGAAGC-TTTTTTCACTCTGGAGACAGAG-3' and 5'-TCCCTGCAGAGTGACCTGAA-CAACTCTCC-3', positions 19 to 38 of the CYP2C8 cDNA plus a HindlIl cleavage site (underlined) and positions 1607 to 1588 plus a PstI cleavage site (underlined), respectively. For the CYP2C9 cDNA, we used: 5'-GCAGTTAACATTTTGGGA-TGGGGAAGAGG-3' and 5'-ACCGGTACCAATGTGAGATGACAGGTGAG-3', positions 77 to 96 plus a HpaI cleavage site (underlined) and positions 1263 to 1244 plus a KpnI cleavage site (underlined). PCR (Saiki et al., 1985) was performed with 200 ng DNA (liver cDNA library), 2.5 ~1 each of oligonucleotide primer (20 ~xM), 10 ~1 of 1 mM dNTPs, 5 [xl of 10 x PCR buffer and 1 U Taq DNA polymerase in a final volume of 50.4 ~1 (ATTO Zymoreactor AB-1800). The reaction was performed under the following conditions: denaturation at 92~ for 1 rain, annealing at 55~ for 1 min, and extension at 72~ for 2 min. After 35 cycles of amplification, the products underwent a final extension at 72~ for 5 rain. A portion of each sample (1 ~1) was analyzed by electrophoresis through a 1 agarose gel containing 1 ~zg/ml ethidium bromide.
MATERIALS AND METHODS

Synthesis of oiigonucieotide
Subcloning and sequencing of the PCR products (CYP2C8 and 2C9). According to the restriction sites of the primers, the amplified DNA fragments by PCR were digested with HindIII and PstI in CYP2C8 and KpnI and Hpal in CYP2Cg, respectively. The PCR products from CYP2C8 and CYP2C9 were ligated with the pBluescriptIIKS(+) vector and transformed into Escherichia coli strain XL-1 using a Gene Pulser apparatus for the electro-transformation E. coli (Bio-Rad). The transformants were selected on agar plates containing ampicillin (50 [zg/ml) and X-Gal/IPTG. The 1.37 kb fragment of CYP2C8 was subcloned into the Hind-III and PstI sites of pBluescriptIIKS(+), and the 1.19 kb fragment of CYP2C9 was subcloned into the KpnI and Sinai sites of pBluescriptlIKS(+). These fragments were sequenced using the AutoRead r~ Sequencing kit according to the directions of the supplier (Pharmacia, Uppsala, Sweden).
Subcloning of CYP2CIO. An M13 phage containing the original MP-8 cDNA described by Brian et al. (t989) was infected with E. coli JM103. The collected phage DNA was digested with EcoRI and the resulting fragment (1.6 kb) was subcloned into the plasmid vector pUC119 as described by Brian et al. (1989) .
Chromosome preparation and fluorescence in situ hybridization. Metaphase chromosome spreads were obtained from normal human lymphocyte cultures and synchronized with thymidine as previously described (Viegas-Pequignot and Dutrillaux, 1978; Inoue et al., 1992) . R-banding was induced by treating cultures with 5-bromodeoxyuridine (BrdU) during the late S-phase. Slides were aged 1-2 days, baked at 65~ for at least 3 h, and kept at -20~ until use.
FISH was performed according to a method recently described for high-resolution mapping of single-copy small genes directly on banded chromosomes (Inazawa et al., 1991; Lemieux et al., 1992; Takahashi et al., 1992; Inoue et al., 1992) . Briefly, chromosomes were denatured in 70~ formamide in 2x SSC (1 x SSC is 0.15 M sodium chloride/0.015 M sodium citrate, pH 7) at 70~ for 2 rain Vol. 39, No. 3, 1994 followed by dehydration in ethanol. The CYP2C8 cDNA probe (containing the 1.37-kb cDNA fragment cloned into pBluescriptIIKS(+)), the CYP2C9 cDNA probe (containing the 1.19-kb cDNA fragment cloned into pBluescriptIIKS(+)) and a CYP2C10 cDNA probe (1.6 kb) were labeled by nick translation using biotin-16-dUTP (Boehringer, Mannheim) for 1.5 h at 15~
The biotinylated probes were denatured at 75~ for 10 rain. The probe concentration on the slides was 500 ng in l0 ~l of the hybridization mixture (50 ~ formamide, 10~ dextran sulfate, 2• SSC, and t0~ bovine serum albumin). Hybridization proceeded for 16-18 h at 37~
After being washed with 50 ~ formamide/2 • SSC, 2 • SSC, and 1 • SSC for 37~ for 15 rain each, the slides were treated with 4 ~ Block Ace T~ (Dainippon Pharmaceutical, Osaka) at 42~ for 10 rain to block fluorochrome background noise. We detected small single-copy genes (1.37-kb insert in CYP2C8 eDNA, 1.19-kb insert in CYP2C9 cDNA, and 1.6-kb insert in CYP2C10 cDNA), by amplification with avidin-conjugated fluorescein isothiocyanate (FITC-avidin) (Boehringer, Mannheim) and a biotinylated anti-avidin antibody (Vector, Burlingame, CA) (Pinkel et al., 1986; Inoue et al., 1992) . Finally, the chromosomes were stained with propidium iodide (l ~g/ml, Sigma, St. Louis, MO). Slides were mounted with a fluorescence anti-fade solution containing 1 ~ DABCO (1,4-diazabicyclo[2,2,2]octane, Sigma) and observed under a fluorescence microscope (filter combinations: B-2A, excitation 450-490 nm, barrier 520 nm; B-2E, excitation 450-490 rim, barrier 520-560 nm). The G-banding pattern on the same metaphase was delineated by means of a different filter combination (UV-2A, excitation 400-440 nm, barrier 470 nm). Photographs were taken using Fujichrome 400D film (800 ASA).
RESULTS AND DISCUSSION
CYP2C8 and CYP2C9 cDNAs (Ged et al., 1988 ) from a human liver cDNA library were amplified by PCR. The primer pairs, positions 19 to 38 and 1607 to 1588 were selected to amplify a 1589 bp region of CYP2C8 and those from positions 77 to 96 and 1263 to i244 of 1187 bp of CYP2C9 were also used. The product of CYP2C9 yielded fragments of the expected size. However, that of CYP2C8 was 1.37-kb long because of a PstI site at position 1383. In order to confirm the CYP2C8 and CYP2C9 sequences in the amplified cDNA fragments, the fragments were subcloned into the vector pBluescriptIIKS(+). The nucleotide sequences obtained from the subclones showed complete identity with the corresponding published sequences (Ged et aI., 1988) .
We performed FISH mapping using these biotin-labeled probes to assign the human CYP2C gene location. The procedure allows the simultaneous identification of the G-banded chromosome pattern and hybridization signals on the same metaphase preparation by simply changing the filters (filter combination B-2A and UV-2A, Nikon). A detailed distribution analysis showed that the hybridization Vol. 39, No. 3, 1994 K. 1NOUE et al. site in the three probes was the same: 10q24 (Fig. !) (Nelson et al., 1993) . The human chromosome localization of the human P450 gene encoding the CYP2C subfamily has been reported by investigators from three different laboratories. Okino et al. (1987) using a panel of human-rodent somatic cell hybrids, have assigned the human P450 1 cDNA (designated Hpl-1), which is neaiy identical with clone MP-20 (CYP2C8), to human chromosome 10. Riddell et al. (1987) and Meehan et al. (1988) using both somatic cell hybridization and isotopic in situ hybridization have also assigned the CYP2C9 to 10q24.1-10q-24.3. Our results obtained by FISH mapping of CYP2CS, 2C9, and 2C10 cDNAs confirmed the previous studies, further suggest that the genes for members of the CYP2C subfamily lie on a limited region of human chromosome 10 at q24.1.
